TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive NCI Cuts Back Directed Research Funds, Encourages Investigator – Initiated Grants February 23, 1996
TCL Archive Budget Manipulations “Wreaking Havoc,” Korn Tells NCAB; Legal Actions Being Considered February 13, 1987